Frank Reed

With a new CEO and focused strategy, Prime Medicine faces investors to prove its 'search and replace' gene editor is worth the wait in a crowded field.

A routine UK filing reveals Driehaus Capital's small sale of Greencore shares, offering a glimpse into active management and market sentiment.

A regulatory filing reveals a key investor's growing stake in Avadel, signaling potential M&A activity for the narcolepsy drugmaker.

Balyasny Asset Management's big bet on Avadel Pharmaceuticals' takeover reveals a fierce battle for LUMRYZ™, a next-gen narcolepsy treatment.

A regulatory filing reveals a top hedge fund's tactical moves in Unite's bid for Empiric, offering a rare glimpse into the high-stakes M&A chess game.

A major hedge fund's regulatory filing reveals a strategic stake in the Unite-Empiric merger, signaling big money's confidence in student property.

Dr. Lynne J. Baldwin of BHMI receives Pioneer Award, recognizing her leadership in back-office payment solutions and commitment to fostering women's entrepreneurship in the Midwest.

Leading clinical research organization AMR Clinical announces a strategic leadership shift as founder Dr. William Smith steps into a Vice Chairman role. The move signals a focus on scaling operations and capitalizing on rising demand for integrated research solutions.

Hallmark Health Care Solutions assembles a powerhouse advisory board of former health system CEOs to address critical workforce challenges and drive innovation in healthcare labor management.

A massive influx of capital and a new advanced pharmaceutical manufacturing center are positioning Virginia as a key player in the reshoring of biopharmaceutical production and the development of a highly-skilled workforce.

A domestic generic drug maker's plea for policy changes highlights the fragility of the U.S. pharmaceutical supply chain, revealing reliance on foreign sources and a complex web of pricing challenges. Can reshoring efforts overcome economic realities?

Clinical trial supply firm Myonex prepares for a new chapter with Greg Lavin stepping into the CEO role. The company's strategic acquisitions and focus on integrated solutions position it for success in an evolving market.

USA Pickleball partners with Epicore Biosystems to monitor athlete hydration levels, pushing the boundaries of performance and wellbeing with real-time sweat analysis. Is this the future of athletic training?

A new program aims to tackle soaring health costs by offering employer-sponsored access to popular weight-loss drugs, potentially expanding access while curbing expenses.

Amid ongoing drug shortages, Phlow Corp. is advocating for a stronger domestic pharmaceutical supply chain. CEO Dr. Eric Edwards testified before Congress, highlighting the need for resilience and innovation in American medicine.

A new weight loss supplement promising rapid results is drawing skepticism as questions emerge regarding its clinical validation, company registration, and scientific backing. Is this a breakthrough or buyer beware?

A potential new FDA initiative aims to drastically reduce response times to drug sponsors, but details remain unconfirmed. Is this a sign of a changing regulatory landscape?

A leading materials science company unveils a potential breakthrough in tire technology, offering an alternative to a chemical linked to the deaths of coho salmon and other aquatic life. The innovation faces regulatory hurdles and competition.

European regulators endorse a novel pertussis vaccine, offering a targeted approach to bolster immunity and address waning protection against the highly contagious respiratory illness.

Molecular Designs launches a new multiplex PCR panel designed to accelerate HPV research, offering improved efficiency and accuracy for scientists studying cancer prevention and treatment.